Industry

Poster Presented at AGBT 2022 General Meeting Demonstrates the NIC+ Improves the Efficiency and Reliability of Nuclei Isolations for Sub-20 mg Samples LIVERMORE, Calif.–(BUSINESS WIRE)–#AGBT2022–S2 Genomics, a manufacturer of automated tissue sample preparation systems, announced today at the Advances in Genome Biology and Technology (AGBT) 2022 general meeting the launch of the NIC+ Small Sample … [Read more…]

A cloud-based, integrated informatics ecosystem for spatial biology with advanced analytics enabling data sharing and collaboration SEATTLE–(BUSINESS WIRE)–#spatialbiology–NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, announced today the commercial unveiling of its new AtoMx™ Spatial Informatics Portal (SIP) at the Spatial Multiomic Symposium at the 2022 … [Read more…]

Lung scaffolds developed in partnership with 3D Systems Corporation represent the most complex objects ever printed; reveal took place at the LIFE ITSELF Conference in San Diego 3D-printed lung scaffolds are demonstrating gas exchange in animal models United Therapeutics expects human clinical trials of 3D-printed, cellularized lungs in the next five years SILVER SPRING, Md. … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Gastroenterology Ambulatory Surgery Center Market Research Report by Services (Diagnostic Services and Surgical Services), Ownership, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Gastroenterology Ambulatory Surgery Center Market size was estimated at USD … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Orthopedic Soft Tissue Repair Market Research Report by Procedure, Injury Location, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Orthopedic Soft Tissue Repair Market size was estimated at USD 4,546.87 million in 2021, USD 5,444.34 million in 2022, and is projected … [Read more…]

TOKYO–(BUSINESS WIRE)–Chlorella Industry Co., Ltd. (Minato-ku, Tokyo) has acquired FDA GRAS (Generally Recognized As Safe) certification for the chlorella powder product, unprecedented in Japan for the exclusively domestic cultivation and production of chlorella. Chlorella is a plant-based food source, made up of about 60% protein, and comprised of a variety of vitamins and minerals, chlorophyll … [Read more…]

Series B co-led by Fast Track Initiative, DCI Partners, and 4BIO Capital Proceeds to accelerate development of LUCA’s novel Mitochondria Isolation Technology (MIT) platform, IND-enabling activities for its in-house pipeline and establish its manufacturing capability TOKYO–(BUSINESS WIRE)–LUCA Science, a global innovator in the development of a novel class of mitochondria biopharmaceutical agents, today announced the … [Read more…]

STRASBOURG, France–(BUSINESS WIRE)–Regulatory News: Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced that it presented updated preliminary Phase I data on TG4050, its individualized neoantigen cancer vaccine, in a poster session at the American Society of Clinical Oncology (ASCO) annual meeting. TG4050 … [Read more…]

A prestigious award for founder Don Stephens and blessing of the Global Mercy™ add to the launch of a packed training schedule designed to increase healthcare capacity in Africa DAKAR, Senegal–(BUSINESS WIRE)–In the midst of celebrations around the arrival of the Global Mercy™ to Senegal, training has already begun by the crew of the world’s … [Read more…]

BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969), a leading biotech company, announced today that Professor Zhanguo Li, the leading PI, has presented latest data of BTK inhibitor orelabrutinib for the treatment of Systemic Lupus Erythematosus (SLE) at the just-concluded EULAR 2022 European Congress of Rheumatology. The abstract was selected as late-breaking oral presentation. Late-breaking Oral Presentation: Orelabrutinib, … [Read more…]